Related Experiment Video
Updated: Jul 19, 2026

5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Aldosterone in progressive renal disease
T H Hostetter1, M E Rosenberg, H N Ibrahim
1Division of Renal Diseases and Hypertension, University of Minnesota, Minneapolis, MN, USA.
Abstract:
Blockade of the renin-angiotensin-aldosterone system has proven effective in retarding progression of renal disease in the remnant kidney model, as well as other experimental diseases, and, most importantly, in a range of progressive human renal diseases. Attention has focused on the role of angiotensin II (Ang II) in propagating progression both by its hemodynamic and nonhemodynamic actions. Recent evidence, predominately in the remnant kidney model, indicates that the drugs used to block this hormone system, angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers, also lower aldosterone levels. Thus, aldosterone, as well as angiotensin II, appears to be instrumental in sustaining the hypertension and fibroproliferative destruction of the residual kidney.
Insights
Blocking the renin-angiotensin-aldosterone system slows kidney disease progression. Both angiotensin II and aldosterone contribute to hypertension and kidney damage, highlighting dual therapeutic targets.
Area of Science:
- Nephrology
- Endocrinology
- Pharmacology
Background:
- Renal disease progression is a significant clinical challenge.
- The renin-angiotensin-aldosterone system (RAAS) plays a critical role in kidney disease.
- Angiotensin II (Ang II) is implicated in both hemodynamic and nonhemodynamic disease progression.
Purpose of the Study:
- To investigate the role of aldosterone in kidney disease progression.
- To evaluate the impact of RAAS blockade on aldosterone levels.
- To understand the combined effects of Ang II and aldosterone in renal pathology.
Main Methods:
- Utilized the remnant kidney model in experimental studies.
- Administered angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.
- Monitored effects on hypertension and fibroproliferative destruction.
Main Results:
- RAAS blockade effectively retards renal disease progression in experimental and human studies.
- Drugs blocking the RAAS also significantly lower aldosterone levels.
- Aldosterone, alongside Ang II, contributes to sustained hypertension and kidney damage.
Conclusions:
- Both Ang II and aldosterone are key mediators of progressive renal injury.
- Targeting both Ang II and aldosterone may offer a more comprehensive therapeutic strategy for kidney disease.
- RAAS blockade demonstrates efficacy by addressing multiple pathogenic pathways in renal disease.
Related Concept Videos
Hormonal Regulation
Antihypertensive Drugs: Potassium-Sparing Diuretics
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Diuretics
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Renal Tubule and Collecting Duct
Proximal Convoluted Tubule (PCT):
The PCT is the initial segment of the renal tubule, extending from the Bowman's capsule that encloses the glomerulus. Its convoluted structure and microvilli-lined cells increase the surface area for reabsorption. The PCT reabsorbs glucose, amino acids, sodium, and water from the filtrate, ensuring essential...

